Home › Kidney Failure
Kidney Failure clinical trials recruiting in the U.S.
50 studies for Kidney Failure are recruiting participants at sites across the United States.
Healthy kidneys clean your blood by removing excess from your body. But if kidneys are damaged, they won't work properly. Read about the treatments.
Cities with the most studies
- Boston, MA14 studies
- Houston, TX13 studies
- Dallas, TX9 studies
- Chicago, IL7 studies
- New York City, NY7 studies
- Queens, NY6 studies
- Orlando, FL5 studies
- Baltimore, MD5 studies
- Phoenix, AZ5 studies
- Atlanta, GA5 studies
- Durham, NC5 studies
- Memphis, TN4 studies
- Jacksonville, FL4 studies
- Los Angeles, CA4 studies
- Greenville, SC4 studies
- Raleigh, NC4 studies
- Charlotte, NC4 studies
- Mountain View, CA4 studies
- Chattanooga, TN3 studies
- San Francisco, CA3 studies
- Riverside, CA3 studies
- Pomona, CA3 studies
- Victorville, CA3 studies
- Kansas City, MO3 studies
- Santa Clarita, CA3 studies
- Santa Monica, CA3 studies
- Tampa, FL3 studies
- Lexington, KY3 studies
- Albuquerque, NM3 studies
- Philadelphia, PA3 studies
- Spartanburg, SC3 studies
- Columbia, SC3 studies
- Rochester, MN3 studies
- St. Louis, MO3 studies
- Tucson, AZ3 studies
- Long Beach, CA3 studies
- Sarasota, FL3 studies
- Seattle, WA3 studies
- The Bronx, NY3 studies
- Norfolk, VA3 studies
By state
- Alabama5 studies
- Arizona5 studies
- California19 studies
- Colorado4 studies
- Florida14 studies
- Georgia9 studies
- Illinois7 studies
- Indiana4 studies
- Iowa3 studies
- Kentucky5 studies
- Maryland5 studies
- Massachusetts16 studies
- Michigan4 studies
- Minnesota5 studies
- Mississippi4 studies
- Missouri6 studies
- Nebraska3 studies
- New Jersey5 studies
- New Mexico4 studies
- New York15 studies
- North Carolina10 studies
- Ohio4 studies
- Pennsylvania7 studies
- South Carolina8 studies
- Tennessee7 studies
- Texas15 studies
- Virginia6 studies
- Washington3 studies
Recently updated studies
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT05485961Decellularized Femoral Artery Allograft (Nexeon AVX) Prospective Registry
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT05880537Partners Calciphylaxis Biobank
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT03032835Study to Evaluate the Safety and Efficacy of the GGTA1 KO Thymokidney in Patients With ESRD
RecruitingPhase 1/2
Ages 40 to 70 · All sexes · Updated Sep 9, 2026 · NCT07224763Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT05287945Pivotal Study of the Velocity™ pAVF System
Recruiting
Ages 18 to 80 · All sexes · Updated Sep 2, 2026 · NCT07153939Duke APOL1 Research Biorepository
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Aug 27, 2026 · NCT04160507Incremental Hemodialysis for Veterans in the First Year of Dialysis (IncHVets)
Recruiting
Ages 18 and older · All sexes · Updated Aug 20, 2026 · NCT05465044A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)
RecruitingPhase 1/2Healthy volunteers welcome
Ages 18 to 55 · All sexes · Updated Aug 14, 2026 · NCT06749457Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System
Recruiting
Ages 18 and older · All sexes · Updated Aug 10, 2026 · NCT04634916Incremental Hemodialysis: The TwoPlus Trial
Recruiting
Ages 18 and older · All sexes · Updated Aug 6, 2026 · NCT05828823Staged Kidney Transplantation During Combined Heart/Kidney Transplantation
Recruiting
Ages 18 and older · All sexes · Updated Jul 24, 2026 · NCT06877169CAPABLE Transplant
Recruiting
Ages 18 to 99 · All sexes · Updated Jul 20, 2026 · NCT06326905Blood Pressure Slopes and Ultrafiltration in Hemodialysis Patients
Recruiting
Ages 18 and older · All sexes · Updated Jul 20, 2026 · NCT04163614Post Market Study for VasQ, an External Support Implant for Arteriovenous Fistula
Recruiting
Ages 18 to 80 · All sexes · Updated Jul 14, 2026 · NCT06516653Virtual Reality in End Stage Kidney Disease
Recruiting
All ages · All sexes · Updated Jul 10, 2026 · NCT06356168AMSC for Reducing Anastomotic Stenosis in Primary Arteriovenous Anastomoses
RecruitingPhase 1
Ages 18 to 85 · All sexes · Updated Jul 10, 2026 · NCT04392206Moda-flx Hemodialysis System™ Under Professional Care Settings by Trained Individuals and At Home by Participants
Recruiting
Ages 18 to 80 · All sexes · Updated Jul 6, 2026 · NCT06613568Effect of the Amplifi™ Vein Dilation System on Outflow Vein Dilation and AV Fistula Maturation (AMPLIFI-1)
Recruiting
Ages 18 and older · All sexes · Updated Jun 23, 2026 · NCT07211035A Study to Assess the Safety and Pharmacokinetics of INCB123667 When Administered Orally to Adult Participants With Severe Renal Impairment or End Stage Renal Disease
RecruitingPhase 1
Ages 18 to 85 · All sexes · Updated Jun 16, 2026 · NCT07559396Preoperative Hemodialysis Timing in Patients With End-Stage Kidney Disease: The POD-ESKD Pilot Trial
Recruiting
Ages 18 and older · All sexes · Updated Jun 11, 2026 · NCT07339202PReSeRVE-HD: Observational Study of the Merit HeRO® Graft and Super HeRO® in Patients on Hemodialysis
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jun 1, 2026 · NCT06422871RaDIANT Health Systems Intervention
RecruitingHealthy volunteers welcome
Ages 18 to 80 · All sexes · Updated May 26, 2026 · NCT07033117Kidney Transplant Improvement Through New Exercise Training to Increase Capacity
Recruiting
Ages 60 and older · All sexes · Updated May 6, 2026 · NCT07446296International (Pediatric) Peritoneal Biobank
RecruitingObservational studyHealthy volunteers welcome
1 Day – 90 Years · All sexes · Updated Apr 30, 2026 · NCT01893710From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.